✦ LIBER ✦

Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder

✍ Scribed by Jay D. Amsterdam; Justine Shults; Nancy Rutherford

Book ID: 116841107
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 270 KB
Volume: 32
Category: Article
ISSN: 0278-5846
DOI: 10.1016/j.pnpbp.2007.07.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness and acceptability of sertr

Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison

✍ Prithpal S. Matreja; Dinesh K. Badyal; Prem Khosla; Randhir S. Deswal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## Objective Citalopram and sertraline are widely prescribed selective serotonin reuptake inhibitors (SSRIs). There is no conclusive evidence to show superiority of citalopram or sertraline in terms of efficacy or tolerability. Hence this study was designed to compare short term effica

P.2.g.008 Efficacy and tolerability of o

P.2.g.008 Efficacy and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

✍ D. Shin; S. Hong 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A comparative evaluation of therapy esci

A comparative evaluation of therapy escitalopram versus memantine in the case of patients with alcohol dependence and co-morbid major depressive disorder

✍ D. Ionescu; C. Dehelean; S. Timofei Funar; R. Dumache 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Duloxetine and care management treatment

Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study

✍ Jordan F. Karp; Debra K. Weiner; Mary A. Dew; Amy Begley; Mark D. Miller; Charle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective In older adults, major depressive disorder (MDD) and chronic low back pain (CLBP) are common and mutually exacerbating. We predicted that duloxetine pharmacotherapy and Depression and Pain Care Management (DPCM) would result in (1) significant improvement in MDD and CLBP a

S.03.02 Fast onset: An open study of the

S.03.02 Fast onset: An open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy

✍ D. Bakish; C.L. Hooper; M. Thornton; A. Wiens; C. Miller; C. Thibaudeau 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 284 KB